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HIGHLY significant growth responses in the rudimentary mammary glands of
intact weanling male mice of the S.A.S.3 strain have been induced by pituitary
prolactin when administered twice daily for five days by subcutaneous injection
(Hadfield and Young, 1956). Compared with the responses produced by oestrone
in the same strain at various dose levels over the same short period of injection,
the mammae of prolactin-treated weanling males showed a significantly greater
degree of glandular differentiation with the production of easily recognisable
acini. Both hormones induced rapid development of the mammary ducts and
ductules.
During the last two years, and until a few months ago, we have injected, twice
daily for five days, a large number of specimens of human female urine into male
weanlings of the S.A.S.3 strain, no other strain being used. Unmistakable
mammary growth reactions have been obtained with the majority of urine
specimens and these show the same degree of duct development and glandular
differentiation which characterises the weanling mammae reacting to prolactin.
Similar reactions to urine were obtained when specimens from normal pre-
menopausal women in the post-ovulatory phase of menstruation were used,
and significant responses were induced by the urine of 57 per cent of post-
menopausal women.
Some months ago the mammary glands of the weanling males of the S.A.S.3
strain showed a precipitate fall in their ability to react both to prolactin and to
human female urine (this has since returned). An extensive search was therefore
made for another strain whose weanling males are sensitive to prolactin and urine.
This has proved successful but the enquiry revealed the disconcerting fact that
in the large majority of common strains of laboratory mice the mammary glands
of the weanling males are quite unresponsive to prolactin and that this
characteristic always appears to be associated with complete mammary in-
sensitivity to human female urine. This observation explains the failure of
several workers to confirm our published experiments which demnonstrated the
mammogenic property of human female urine when the "sensitive" mamma of
S.A.S.3 weanling males was used as the "indicator ".
Other relevant facts have emerged from this enquiry. They throw some light
on the nature of the mammotrophic hormone present in the urine of normal
women and the present paper is a record of experiments dealing with these
problems.
METHODS
For each experiment five or more weanling males, aged 25 days on the day of
the first injection, were used. They were given 0.2 ml. twice a day for a periodINDUCTION OF MAMMOGENESIS 117
offive days, ofthe untreated urine ofnormalpre-menopausal women in the second
halfofthe menstrual cycle, or 0.1 ml. ofoestrone or 0.1 ml. ofprolactin in varying
concentrations (seebelow). The intensity ofthe mammaryresponse was measured
by counting the end-bulbs or clubs in each gland. The yield of mammary glands
per weanling was 5 or 6, so each batch of five animals produced about 27 glands.
The average number of clubs per gland is taken to be a reasonably accurate
measure ofgrowth response. The average number ofclubs per gland in untreated
male weanlings in the strains examined was less than 1 in the majority and only
fractionally over 1 in the remaining few.
TABLE I.-Strains of Mice Investigated
Strain Source of supply
Non-inbred
Schneider . . . . Medical Research Council.
Parkes . . . ..
Stock . . . Chester Beatty Research Institute.
Grey . . . Laboratory Animals Bureau, Medical
Research Council.
Swiss . . . Evans.
Schneider . . . . Tuck.
No.1 . . . .
No. 2
Tyler's originals . . . .
S.A.S.3 . Scientific Animal Service.
S.A.S.4 (Tyler's originals) . .. .. ..
In-bred:
C3H . . . . . Imperial Cancer Research Fund, Mill
Hill Laboratories.
C57B1 . . . . ,, , ,
C- . . . Chester Beatty Research Institute.
C+ . . . .. .. .. ..
C3H .. ,,
Hairless . .. ,, ,, ,
C57B1 . .. ,, I
CBA . . . . .
Strong A . . . Laboratory Animals Bureau, Medical
Research Council.
AKR . . .. .
BALB
C57Br . . . . .
CE . . ...
C3H . . . . Medical Research Council.
Strong A . . . Guy's Hospital Medical School.
BALB . . . .
A2G . . . . Glaxo Laboratories.
GFF
JU . . . . Institute of Animal Genetics, Uni-
versity of Edinburgh.
RIII . . ...
F1 crosses from in-bred strains:
AKR X CE . . . Laboratory Animals Bureau, Medical
Research Council.
AKR X BALB . . ..
DBA x A .. . . ..
CE xA .
CE x BALB
A x BALB .
Urines proved to be potent failed to produce a significant mammary growth response in any of
these 37 strains. Twelve of these strains, including the reacting S.A.S.3 and A2G, were further
examined for their ability to react to oestrone and prolactin. The strains were selected because of
their popularity as experimental animals and their ready'availability.STRETTON YOUNG
RESULTS
Thirty-seven strains, as shown in Table I, have been examined.
Response to urine.-The mammae of A2G mice were found to react vigorously
to normal pre-menopausal urine and as the S.A.S.3 mice were found to have
regained their previous sensitivity, a batch ofweanlings from each ofthese strains
was included in every experiment as controls. This indicated whether the urine
was active or not and gave a measure of its potency.
Response tooestrone.-Using oestrone (B.D.H.) dissolvedin 50per cent aqueous
propylene glycol, the optimum dose level was determined over a total dose range
of 0.001 to 1.0 ,ug. given in ten injections over a period of five days. The latter
concentration was selected as giving a typical and vigorous response and oestrone
at this level was therefore administered to groups of animals from each of the
twelve strains, including A2G and S.A.S.3. Unmistakable mammary growth
responses were induced in all strains without exception.
Response toprolactin.-Prolactin (Squibb) dissolved in distilled water contain-
ing 0.5 per cent phenol was administered to A2G and S.A.S.3 mice over a total
dose range of 0.004 to 40.0 international units (by pigeon crop assay) given twice
daily for a period of five days. Forty i.u. was selected as an appropriate total
dose. This was administered to animals from each of the 12 strains used for the
oestrone response, again including A2G and S.A.S.3. Excluding the two latter,
prolactin failed to elicit any significant mammary response in the remaining
10 strains. In S.A.S.3 and A2G weanlings the reactions were unmistakable but
rather less vigorous in the S.A.S.3 animals. The results are summarised in





Between 35 and 45 . 4-
Between 4.5 and7 O . +
Over 7.0 . . . ++
CONCLUSIONS
1. The mammary growth responses to human urines known to possess mam-
motrophic potency have been investigated in the weanling males of 37 strains of
laboratory mice. In two strains only-S.A.S.3 and A2G-was a significant
growth response induced.
2. Twelve of these strains, including those possessing mammary sensitivity to
human pre-menopausal female urine, responded satisfactorily to oestrone; the
reaction was confined to the duct system; there was little or no glandular
acinisation.
3. Two strains only-S.A.S.3 and A2G-responded to prolactin. In these the
response was vigorous and unmistakable and early acinisation was common.
4. Strains responding to prolactin also responded satisfactorily to human
female urine.
5. Strains failing to respond to prolactin failed to respond to human female
urine.
6. These results support the contention that the mammotrophic agent present
in human pre-menopausal female urine is prolactin.
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TABLE II.-Mammary Growth Response in Various Strains of Mice Induced by
Oestrone, Prolactin and Human Female Urinefrom Normal Pre-menopausal
Women: Injections Twice a Dayfor Five Days.
Degree of response induced
Oestrone: Prolactin: Urine:
Total Total Total
Strain of dose dose dose
mice Source of supply 1-0 pg. 40 i.u. 2.0 ml.
'on-inbred:
S.A.S.3 . . Scientific Animal Service . + + + +
S.A.S.4 . . ,, ,, ,, . + - -
Schneider . . Medical Research Council . + + - -
Parkes .. . ,, ,, ,, ++ - -
Grey . . . Laboratory Animals Bureau, Medical . ±+ - -
Research Council
In-bred:
A2G . . . Glaxo Laboratories . ++ + ++
A . . . Laboratory Animals Bureau, Medical . 0 - -
Research Council
A . . Atomic Energy Research Establish- + -
ment, Harwell
BALB . . Laboratory Animals Bureau, Medical . ++ - -
Research Council
C3H . . . Chester Beatty Research Institute . + --
C57B1 . . . ,, ,, ,, ,, ++ - -
Fl crosses from in-
bred strains:
CE x BALB . Laboratory Animals Bureau, Medical . + + - -
Research Council
AKR X BALB ,, ,, . ++ -
0 = Not investigated.
7. Weanling males of the A2G strain of mice are suitable for detection of the
mammotrophic agent present in human female urine. Weanlings of the large
majority of other strains are quite unsuitable.
We are indebted for supplies of animals to Dr. J. Craigie, Dr. W. F. J.
Cuthbertson, Dr. D. S. Falconer, Dr. P. A. Gorer and Professor A. Haddow. Dr.
W. S. Lane Petter of the Laboratory Animals Bureau, Medical Research Council,
has not only arranged for supplies ofmice but has given valuable help and advice.
MIessrs. E. R. Squibb and Sons kindly supplied the prolactin used in these
experiments.
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